Atlas Trials

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

Clinical trial NCT05455606 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05455606
Sponsor
SWOG Cancer Research Network
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm
Start date
2022-10-14
Primary completion
2026-12-15
Enrollment
1284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.